Literature DB >> 31700873

Evaluation of the BioFire FilmArray meningitis/encephalitis panel for the detection of bacteria and yeast in Chinese children.

Bailu Du1, Chunzhen Hua2, Yijun Xia3, Jin Li1, Yongping Xie2, Yue Tao4, Qing Cao1, Xi Mo4.   

Abstract

BACKGROUND: Meningitis and encephalitis are life-threatening syndromes with high morbidity and mortality in children. Due to limitations of traditional laboratory approaches in etiological diagnosis, the rate of misdiagnoses is unacceptably high.
METHODS: We retrospectively compared the potential clinical impact of the FilmArray meningitis/encephalitis (ME) panel vs. conventional cerebrospinal fluid (CSF) culture in children with central nervous system (CNS) infections. Sixty-eight pediatric patients (<18 years of age) with an initial diagnosis of meningitis or encephalitis were enrolled at 2 children's hospital from January to October 2017.
RESULTS: Fifteen specimens were found to be positive after CSF culture, with a positive rate of 22.1% (15/68). For the FilmArray ME panel, 26 bacteria and fungi from 25 samples were detected, and the positive rate was 36.8% (25/68). The FilmArray ME panel identified 14 pathogens in previously pathogen-negative patients.
CONCLUSIONS: This study demonstrated the capability of the FilmArray ME panel in the diagnosis of bacterial and fungal meningitis and therefore its potential use in facilitating enhanced patient care. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  FilmArray ME panel; Meningitis; encephalitis; molecular diagnostic tests; rapid diagnosis

Year:  2019        PMID: 31700873      PMCID: PMC6803227          DOI: 10.21037/atm.2019.08.103

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  29 in total

1.  Long term outcome of neonatal meningitis.

Authors:  J P Stevens; M Eames; A Kent; S Halket; D Holt; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

Review 2.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Dexamethasone and bacterial meningitis in Pakistan.

Authors:  S A Qazi; M A Khan; N Mughal; M Ahmad; B Joomro; Y Sakata; N Kuriya; T Matsuishi; K A Abbas; F Yamashita
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

4.  Enhanced Identification of Group B Streptococcus and Escherichia Coli in Young Infants with Meningitis Using the Biofire Filmarray Meningitis/Encephalitis Panel.

Authors:  Harbir Singh Arora; Basim I Asmar; Hossein Salimnia; Prashant Agarwal; Sanjay Chawla; Nahed Abdel-Haq
Journal:  Pediatr Infect Dis J       Date:  2017-07       Impact factor: 2.129

Review 5.  Neonatal meningitis.

Authors:  P T Heath; N K Nik Yusoff; C J Baker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

6.  The causative organisms of bacterial meningitis in Korean children in 1996-2005.

Authors:  Hye Kyung Cho; Hyunju Lee; Jin Han Kang; Kwang Nam Kim; Dong Soo Kim; Yun Kyung Kim; Jung Soo Kim; Jong-Hyun Kim; Chang Hwi Kim; Hwang Min Kim; Su-Eun Park; Sung Hee Oh; Eun Hee Chung; Sung Ho Cha; Young Youn Choi; Jae Kyun Hur; Young Jin Hong; Hoan Jong Lee; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

7.  Clinical characteristics and outcome of clinically diagnosed viral encephalitis in southwest China.

Authors:  Lei Zhao; Muke Zhou; Bin Wang; Jian Guo; Ning Chen; Li He
Journal:  Neurol Sci       Date:  2015-07-24       Impact factor: 3.830

8.  Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998-2004).

Authors:  S Afifi; M O Wasfy; M A Azab; F G Youssef; G Pimentel; T W Graham; H Mansour; N Elsayed; K Earhart; R Hajjeh; F Mahoney
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-05       Impact factor: 5.103

9.  Population-based surveillance for bacterial meningitis in China, September 2006-December 2009.

Authors:  Yixing Li; Zundong Yin; Zhujun Shao; Manshi Li; Xiaofeng Liang; Hardeep S Sandhu; Stephen C Hadler; Junhong Li; Yinqi Sun; Jing Li; Wenjing Zou; Mei Lin; Shuyan Zuo; Leonard W Mayer; Ryan T Novak; Bingqing Zhu; Li Xu; Huiming Luo
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

10.  Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010.

Authors:  Benjamin P George; Eric B Schneider; Arun Venkatesan
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more
  5 in total

1.  Evaluation of cerebrospinal fluid and blood parameters finding in early diagnosis and drug therapy of suspected bacterial meningitis in neonates.

Authors:  Huixian Li; Rui Xiao; Ruheena Javed; Kuanrong Li; Weitao Ye; Wei Zhou; Huiying Liang
Journal:  J Res Med Sci       Date:  2020-08-24       Impact factor: 1.852

2.  Rapid identification of pathogens involved in pediatric osteoarticular infections by multiplex PCR.

Authors:  Chi Gan; Jinfeng Hu; Qing Cao; Ruike Zhao; Yuchan Li; Zhigang Wang; Yue Tao; Xi Mo
Journal:  Ann Transl Med       Date:  2020-03

3.  Case Report: Prolonged CSF PCR Positivity in a Neonate With GBS Meningitis.

Authors:  Nourah Alruqaie; Yara Falatah; Fawaz Alzahrani; Musaed Alharbi
Journal:  Front Pediatr       Date:  2021-11-25       Impact factor: 3.418

4.  Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta-analysis.

Authors:  Juliana Trujillo-Gómez; Sofia Tsokani; Catalina Arango-Ferreira; Santiago Atehortúa-Muñoz; Maria José Jimenez-Villegas; Carolina Serrano-Tabares; Areti-Angeliki Veroniki; Ivan D Florez
Journal:  EClinicalMedicine       Date:  2022-02-14

Review 5.  Rapid Diagnostic Tests for Meningitis and Encephalitis-BioFire.

Authors:  Eduardo Fleischer; Paul L Aronson
Journal:  Pediatr Emerg Care       Date:  2020-08       Impact factor: 1.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.